Literature DB >> 8270135

Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.

C Fanelli1, A Di Vincenzo, F Modarelli, M Lepore, M Ciofetta, L Epifano, S Pampanelli, P Brunetti, G B Bolli.   

Abstract

It is controversial as to whether ketone bodies are utilized by the human brain as a fuel alternative to glucose during hypoglycaemia. To clarify the issue, we studied 10 normal volunteers during an experimental hypoglycaemia closely mimicking the clinical hypoglycaemia of patients with Type 1 (insulin-dependent) diabetes mellitus or insulinoma. Hypoglycaemia was induced by a continuous infusion of insulin (0.40 mU.kg-1.min-1 for 8 h, plasma insulin approximately 180 pmol/l) which decreased the plasma glucose concentration to approximately 3.1 mmol/l during the last 3 h of the studies. Subjects were studied on two occasions, i.e. spontaneous, counterregulatory-induced post-hypoglycaemic increase in 3-beta-hydroxybutyrate (from approximately 0.2 to approximately 1.1 mmol/l at 8 h), or prevention of post-hypoglycaemic hyperketonaemia (plasma beta-hydroxybutyrate approximately 0.1 mmol/l throughout the study) after administration of acipimox, a potent inhibitor of lipolysis. In the latter study, glucose was infused to match the hypoglycaemia observed in the former study. The glycaemic thresholds and overall responses of counterregulatory hormones, symptoms (both autonomic and neuroglycopenic), and deterioration of cognitive function (psychomotor tests) were superimposable in the control study in which ketones increased spontaneously after onset of hypoglycaemic counterregulation, as compared to the study in which ketones were suppressed (p = NS). The fact that responses of counterregulatory hormones, symptoms and deterioration in cognitive function were not exaggerated when posthypoglycaemic hyperketonaemia was prevented, indicate that during hypoglycaemia, the counterregulatory-induced endogenous hyperketonaemia does not provide the human brain with an alternative substrate to glucose. Thus, it is concluded that during hypoglycaemia, endogenous hyperketonaemia does not contribute to brain metabolism and function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270135     DOI: 10.1007/bf00401065

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

Authors:  E A McGuire; J H Helderman; J D Tobin; R Andres; M Berman
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

2.  Enzymes of ketone-body utilisation in human brain.

Authors:  M A Page; D H Williamson
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

3.  Effects of ketone body infusion on hypoglycemic reaction in postabsorptive dogs.

Authors:  J P Flatt; G L Blackburn; G Randers; J B Stanbury
Journal:  Metabolism       Date:  1974-02       Impact factor: 8.694

4.  Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.

Authors:  J J Bending; J C Pickup; A C Collins; H Keen
Journal:  Diabetes Care       Date:  1985 Jan-Feb       Impact factor: 19.112

5.  Effect of acetate on hypoglycemic seizures in mice.

Authors:  D Urion; H J Vreman; M W Weiner
Journal:  Diabetes       Date:  1979-11       Impact factor: 9.461

Review 6.  Hypoglycemia unawareness.

Authors:  J E Gerich; M Mokan; T Veneman; M Korytkowski; A Mitrakou
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

7.  Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.

Authors:  A Mitrakou; C Ryan; T Veneman; M Mokan; T Jenssen; I Kiss; J Durrant; P Cryer; J Gerich
Journal:  Am J Physiol       Date:  1991-01

8.  Incidence of nocturnal hypoglycaemia in insulin-dependent diabetic patients on intensive therapy.

Authors:  I Bendtson; A Kverneland; S Pramming; C Binder
Journal:  Acta Med Scand       Date:  1988

9.  Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

Authors:  P De Feo; V Gallai; G Mazzotta; G Crispino; E Torlone; G Perriello; M M Ventura; F Santeusanio; P Brunetti; G B Bolli
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

10.  Homeostasis during hypoglycemia: central control of adrenal secretion and peripheral control of feeding.

Authors:  E M Stricker; N Rowland; C F Saller; M I Friedman
Journal:  Science       Date:  1977-04-01       Impact factor: 47.728

View more
  2 in total

Review 1.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

2.  Targeting energy metabolism in brain cancer: review and hypothesis.

Authors:  Thomas N Seyfried; Purna Mukherjee
Journal:  Nutr Metab (Lond)       Date:  2005-10-21       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.